Effect of (R)-2-(2-aminothiazol-4-yl)-4′-{2-[(2-hydroxy-2- phenylethyl)amino]ethyl} acetanilide (YM178), a novel selective β3-adrenoceptor agonist, on bladder function

Journal of Pharmacology and Experimental Therapeutics

Volumn 321, Issue 2, 2007, Pages 642-647

  Takasu, Toshiyuki ^a   Ukai, Masashi ^a   Sato, Shuichi ^a   Matsui, Tetsuo ^a   Nagase, Itsuro ^a   Maruyama, Tatsuya ^a   Sasamata, Masao ^a   Miyata, Keiji ^a   Uchida, Hisashi ^b   Yamaguchi, Osamu ^b  

^a ASTELLAS PHARMA INC   (Japan)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINOTHIAZOL 4 YL) 4' [2 [(2 HYDROXY 2 PHENYLETHYL)AMINO]ETHYL]ACETANILIDE; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; BETA3 ADRENOCEPTOR AGONIST; CARBACHOL; G PROTEIN COUPLED RECEPTOR; ISOPRENALINE; UNCLASSIFIED DRUG; YM 178;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER FUNCTION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG STRUCTURE; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL;

ACETANILIDES; ADRENERGIC BETA-AGONISTS; ANIMALS; CARBACHOL; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; HUMANS; ISOPROTERENOL; MUSCLE CONTRACTION; PROPANOLAMINES; RECEPTORS, ADRENERGIC, BETA-3; THIAZOLES; URINARY BLADDER;

EID: 34247205378     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.115840     Document Type: Article

References (28)

1. Arch JRS, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C, and Wilson S (1984) Atypical β-adrenoceptors on brown adipocytes as a target for anti-obesity drugs. Nature (Lond) 309:163-165.
2. Berkowitz DE, Nardone NA, Smiley RM, Price DT, Kreutter DK, Fremeau RT, and Schwinn DA (1995) Distribution of β3-adrenoceptor mRNA in human tissues. Eur J Pharmacol 289:223-228.
3. Daniels DV, Meloy TD, Loury DN, Watson N, Hegde SS, Ford APDW, and Eglen RM (1999) Functional pharmacological characterization of the muscarinic cholinoceptor-mediated inhibition of adenylyl cyclase in primary cultured human bladder detrusor smooth muscle cells. Life Sci 64:590.
4. Dolan JA, Muenkel HA, Burns MG, Pellegrino SM, Fraser CM, Pietri F, Strosberg AD, Largis EE, Dutia MD, Bloom JD, et al. (1994) β-3 Adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines. J Pharmacol Exp Ther 269: 1000-1006.
5. 3-adrenergic receptor. Science (Wash DC) 245:1118-1121.
6. Frazier EP, Mathy MJ, Peters SLM, and Michel MC (2005) Does cyclic AMP mediate rat urinary bladder relaxation by isoproterenol? J Pharmacol Exp Ther 313:260-267.
7. Fujimura T, Tamura T, Tsutsumi T, Yamamoto T, Nakamura K, Koibuchi Y, Kobayashi M, and Yamaguchi O (1999) Expression and possible functional role of the β3-adrenoceptor in human and rat detrusor muscle. J Urol 161:680-685.
8. 2 receptor knockout mice. Neurourol Urodyn 25:590-591.
9. 3-adrenergic receptor. Mol Pharmacol 40:895-899.
10. 3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. Br J Pharmacol 120:1409-1418.
11. Hu B and Jennings LL (2003) Orally bioavailable beta 3-adrenergic receptor agonists as potential therapeutic agents for obesity and type-II diabetes. Prog Med Chem 41:167-194.
12. Igawa Y, Yamazaki Y, Takeda H, Akahane M, Ajisawa Y, Yoneyama T, and Nishizawa O (1998) Possible β3-adrenoceptor-mediated relaxation of the human detrusor. Acta Physiol Scand 164:117-118.
13. 3-adrenoceptor in the human detrusor muscle. Br J Pharmacol 126:819-825.
14. 3 muscarinic receptors in overactive bladder. Urology 55:47-49.
15. Igawa Y, Yamazaki Y, Takeda H, Kaidoh K, Akahane M, Ajisawa Y, Yoneyama T, Nishizawa O, and Andersson KE (2001) Relaxant effects of isoproterenol and selective β3-adrenoceptor agonists on normal, low compliant and hyperreflexic human bladders. J Urol 165:240-244.
16. Kaidoh K, Igawa Y, Takeda H, Takeda Y, Takeda H, Yamazaki Y, Akahane S, Miyata H, Ajisawa Y, Nishizawa O, et al. (2002) Effects of selective β2 and β3-adrenoceptor agonists on detrusor hyperreflexia in conscious cerebral infarcted rats. J Urol 168:1247-1252.
17. Langin D, Portillo MP, Saulnier-Blache JS, and Lafontan M (1991) Coexistence of three β-adrenoceptor subtypes in white fat cells of various mammalian species. Eur J Pharmacol 199:291-301.
18. Liggett SB (1992) Functional properties of the rat and human β3-adrenergic receptors: differential agonist activation of recombinant receptors in Chinese hamster ovary cells. Mol Pharmacol 42:634-637.
19. Longhurst PA and Levendusky M (1999) Pharmacological characterization of β-adrenoceptors mediating relaxation of the rat urinary bladder in vitro. Br J Pharmacol 127:1744-1750.
20. 3-adrenergic receptor: relationship with the atypical receptor of adipocytes. EMBO (Eur Mol Biol Organ) J 10:3721-3727.
21. Nomiya M and Yamaguchi O (2003) A quantitative analysis of mRNA expression of α1 and β-adrenoceptor subtypes and their functional roles in human normal and obstructed bladders. J Urol 170:649-653.
22. 3-adrenoceptor subtypes in relation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods. J Pharmacol Exp Ther 288:1367-1373.
23. 2-induced bladder hyperactivity and on the cardiovascular system in conscious rats. Neurourol Urodyn 21:558-565.
24. Wilson S, Chambers JK, Park JE, Ladurner A, Cronk DW, Chapman CG, Kallender H, Browne MJ, Murphy GJ, and Young PW (1996) Agonist potency at the cloned human beta-3 adrenoceptor depends on receptor expression level and nature of assay. J Pharmacol Exp Ther 279:214-221.
25. Woods M, Carson N, Norton NW, Sheldon JH, and Adgentieri TM (2001) Efficacy of the β3-adrenergic receptor agonist CL-316243 on experimental bladder hyperreflexia and detrusor instability in the rat. J Urol 166:1142-1147.
26. Yamaguchi O (2002) β3-Adrenoceptors in human detrusor muscle. Urology 59 (Suppl 5A):25-29.
27. Yamazaki Y, Takeda H, Akahane M, Igawa Y, Nishizawa O, and Ajisawa Y (1998) Species differences in the distribution of β-adrenoceptor subtypes in bladder smooth muscle. Br J Pharmacol 124:593-599.
28. Yarker YE, Goa KL, and Fitton A (1995) Oxybuthynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drugs Aging 6:243-250.